CatalystMarker
← board

TCNNF

distress 1/10 · well-funded / low risk
$8.79+2%today-13% from 52w high
trulieve.com5,000 employeesFounded 1940Tallahassee, FL
Revenue
$287M
Liquidity
$353M
Runway
Shares 1y

Price & events

-10.9% over 6M
$8.50$9.30$10.10Jun 26Jul 26Jul 264.1M
CatalystRating changeDilutionFinancingdashed = today
+2.0%
1D
+2.0%
1W
-7.0%
1M
3M
6M
1Y
2Y
5Y
-10.9%
All

Overview

Volume
582.84K
52 Week Range
$8.50 – $10.10
Float Shares
167.61M
% Held by Insiders
1.34%
% Held by Institutions
0.04%
RVOL
0.32x
Beta
1.68

Pipeline · 0 trials · 0 upcoming

ReadoutPhaseDrugIndicationEnrollStatus
No pipeline trials tracked.

Catalyst news & presentations · 1

Approved drugs (0)

  • none — clinical-stage

Capital structure — dilution & financing

Shares out: · 0 offerings/1y · 0 PIPEs
  • none
🔒 Positioning — Pro
Short interest / days-to-cover, insider buys & sells.
Upgrade to Pro
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to Pro

Wall St ratings

strong buy · target $18 (+106% upside) · 4 analysts
  • 2024-08-06NeedhamBuy

Competitors

  • none identified

Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.